Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Larissa Seidmann"'
Autor:
Nadine Lehmann, Claudia Paret, Khalifa El Malki, Alexandra Russo, Marie Astrid Neu, Arthur Wingerter, Larissa Seidmann, Sebastian Foersch, Nicole Ziegler, Lea Roth, Nora Backes, Roger Sandhoff, Joerg Faber
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Papillary renal cell carcinoma (PRCC) is a rare entity in children with no established therapy protocols for advanced diseases. Immunotherapy is emerging as an important therapeutic tool for childhood cancer. Tumor cells can be recognized and killed
Externí odkaz:
https://doaj.org/article/e138c3c0e30c4a50b0b943bb2fc60865
Autor:
Alexandra Russo, Claudia Paret, Francesca Alt, Jürgen Burhenne, Margaux Fresnais, Wolfgang Wagner, Martin Glaser, Hannah Bender, Sabrina Huprich, Patrick N. Harter, Katharina Filipski, Nadine Lehmann, Nora Backes, Lea Roth, Larissa Seidmann, Clemens Sommer, Marc A. Brockmann, Torsten Pietsch, Marie A. Neu, Arthur Wingerter, Jörg Faber
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 17, p 4267 (2019)
The insulin-like growth factor (IGF) pathway plays an important role in several brain tumor entities. However, the lack of inhibitors crossing the blood−brain barrier remains a significant obstacle for clinical translation. Here, we targeted the IG
Externí odkaz:
https://doaj.org/article/1e910f23e4c146c898b6d61725250cc8
Autor:
Nadine Vewinger, Sabrina Huprich, Larissa Seidmann, Alexandra Russo, Francesca Alt, Hannah Bender, Clemens Sommer, David Samuel, Nadine Lehmann, Nora Backes, Lea Roth, Patrick N. Harter, Katharina Filipski, Jörg Faber, Claudia Paret
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 12, p 3027 (2019)
(1) Background: The high-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a highly malignant tumor. Preclinical models and molecular targets are urgently required for this cancer. Previous data suggest a
Externí odkaz:
https://doaj.org/article/91e21fd6f8f047bdb6518a70a6a1821a
Autor:
Julia Sturm, Heiko Milera, Stephanie Essmann, Anja Fruth, Antje Jahn-Eimermacher, Mareike Selig, Jennifer Winter, Larissa Seidmann, Christoph Kampmann, André Kidszun, Eva Mildenberger, Catharina Whybra
Publikováno v:
Journal of Perinatal Medicine. 50:985-992
Objectives The prognosis of nonimmune hydrops fetalis (NIHF) is still poor with a high mortality and morbidity rate despite progress in perinatal care. This study was designed to investigate etiology and outcome of NIHF. Methods A retrospective revie
Publikováno v:
Placenta. 105:41-49
Fetal hypoxic events with unclear predictive value are a common indication for placenta examination. We evaluated whether the use of CD15 immunostaining can improve the assessment of severity and duration of fetal hypoxia.We compared placentas (37-42
Autor:
Claudia Paret, Arsenij Ustjanzew, Sara Ersali, Larissa Seidmann, Richard Jennemann, Nicole Ziegler, Khalifa El Malki, Alexandra Russo, Arthur Wingerter, Franziska Ortmüller, Angelina Bornas, Pia Charlotte Wehling, Adina Lepădatu, Malte Ottenhausen, Wilfried Roth, Clemens Sommer, Barbara Fliss, Katrin B. M. Frauenknecht, Roger Sandhoff, Jörg Faber
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6051
Neuroblastoma (NBL) and medulloblastoma (MB) are aggressive pediatric cancers which can benefit from therapies targeting gangliosides. Therefore, we compared the ganglioside profile of 9 MB and 14 NBL samples by thin layer chromatography and mass spe
Autor:
Claudia, Paret, Nadine, Lehmann, Hannah, Bender, Maximilian, Sprang, Clemens J, Sommer, Denis, Cana, Larissa, Seidmann, Arthur, Wingerter, Marie A, Neu, Khalifa, El Malki, Francesca, Alt, Lea, Roth, Federico, Marini, Malte, Ottenhausen, Martin, Glaser, Markus, Knuf, Alexandra, Russo, Joerg, Faber
Publikováno v:
Cancers
Simple Summary Medulloblastoma is the most common malignant childhood brain tumor and it is considered poor immunogenic because of its low mutational burden. Nevertheless, several clinical trials are currently evaluating immunotherapy for medulloblas
Autor:
Doris Leithner, Emily S. Payne, Oliver Kempski, Axel Heimann, Timo A. Auer, Stefanie Kirschner, Lukas Müller, Larissa Seidmann, Yasemin Tanyildizi, Julia Masomi-Bornwasser, Roman Kloeckner, Marc A. Brockmann, Naureen Keric, Samantha Krost-Reuhl, Felix Hahn, Tiemo S. Gerber
Clot-retrieval failure and embolism in new territories (ENT) are complications reducing the efficacy of mechanical thrombectomy (MT). Reasons for these problems are clot abruption during stent retriever retraction into the cylindrical tip of a standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c64617b8def5784c738c35f150e5cbb0
https://doi.org/10.21203/rs.3.rs-154431/v1
https://doi.org/10.21203/rs.3.rs-154431/v1
Autor:
Lea Roth, Gundula Staatz, Alexandra Russo, Frank Traub, Arthur Wingerter, Thomas Kindler, Larissa Seidmann, Clemens Sommer, Daniel-Christoph Wagner, Nadine Lehmann, Katrin Frauenknecht, Henrike Otto, Claudia Paret, André Lollert, Khalifa El Malki, Roger Sandhoff, Nadine Vewinger, Joerg Faber
Publikováno v:
Cancers; Volume 13; Issue 3; Pages: 520
Cancers
Cancers, Vol 13, Iss 520, p 520 (2021)
Cancers
Cancers, Vol 13, Iss 520, p 520 (2021)
Simple Summary Osteosarcoma, Ewing’s sarcoma, and H3K27M-mutant diffuse midline glioma are rare but aggressive malignancies occurring mainly in children. Due to their rareness and often fatal course, drug development is challenging. Here, we repurp
Autor:
Olaf, Beck, Claudia, Paret, Alexandra, Russo, Jürgen, Burhenne, Margaux, Fresnais, Kevin, Steimel, Larissa, Seidmann, Daniel-Christoph, Wagner, Nadine, Vewinger, Nadine, Lehmann, Maximilian, Sprang, Nora, Backes, Lea, Roth, Marie Astrid, Neu, Arthur, Wingerter, Nicole, Henninger, Khalifa El, Malki, Henrike, Otto, Francesca, Alt, Alexander, Desuki, Thomas, Kindler, Joerg, Faber
Publikováno v:
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 793 (2020)
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 793 (2020)
Osteosarcoma (OS) is the second most common cause of cancer-related death in pediatric patients. The insulin-like growth factor (IGF) pathway plays a relevant role in the biology of OS but no IGF targeted therapies have been successful as monotherapy